Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now
Quote Panel
Key Metrics
Fundamentals
Relative Strength
603538.SS
Sector
Top 5 RS in Group
Symbol | Company | RS | 5-Day Perf. |
|---|---|---|---|
Forecast
Analyst rating
Last analyst upgrade/downgrade
Earnings Growth
YoY
Current
Estimates
Q4.22
+1588%
0.54
vs 0.03
Q1.23
-2%
0.53
vs 0.54
Q2.23
N/A
-0.06
vs 0.32
Q3.23
-23%
0.1
vs 0.13
Q4.23
N/A
-0.14
vs 0.54
Q1.24
-87%
0.07
vs 0.53
Q2.24
+141%
0.02
vs -0.06
Q3.24
+109%
0.21
vs 0.1
Q4.24
+112%
0.02
vs -0.14
Q1.25
+43%
0.1
vs 0.07
Sales Growth
YoY
Current
Estimates
Q4.22
-33%
226.3M vs 339.4M
Q1.23
-51%
246.3M vs 500.2M
Q2.23
-15%
335.9M vs 397.1M
Q3.23
+4%
346.3M vs 333.4M
Q4.23
+27%
288M vs 226.3M
Q1.24
+7%
262.8M vs 246.3M
Q2.24
+3%
345.1M vs 335.9M
Q3.24
-1%
341.2M vs 346.3M
Q4.24
+47%
423.8M vs 288M
Q1.25
+5%
276.5M vs 262.8M
Return on Equity
QoQ
Q2.23
-1%
-0.01
vs 0.02
Q3.23
+1%
0.01
vs -0.01
Q4.23
-2%
-0.02
vs 0.01
Q1.24
+1%
0.01
vs -0.02
Q2.24
+0%
0
vs 0.01
Q3.24
+2%
0.02
vs 0
Q4.24
+0%
0
vs 0.02
Q1.25
+1%
0.01
vs 0
Institutionnal Ownership
Relative Strength
603538.SS
Sector
Top 5 RS in Group
Symbol | Company | RS | 5-Day Perf. |
|---|---|---|---|
Quote Panel
Key Metrics
Forecast
604%2026-Revenue
875%2026-EPS
1065%2026-EBITDA
Analyst rating
Strong Sell
Sell
Buy
Neutral
Strong Buy
Price Target
NaN(-100.00%)
Number of analyst
Last analyst upgrade/downgrade
No Data Available
Ningbo Menovo Pharmaceutical Co., Ltd. research, develops, produces, and sells pharmaceutical products. It offers APIs, intermediates, and formulations for the treatment of cardiovascular, central nervous, respiratory, antitumor, anti-infection, digestive, and geriatric diseases, as well as antiviral. The company was founded in 2004 and is headquartered in Ningbo, China.
SHH
-1.08Â ( -4.47%)
Relative Strenght
Volume Buzz
70%
Earning Acce
No
Dist 52w H.
18%Fundamentals
P/E Ratio
P/S Ratio
P/B Ratio
Debt/Equity
Net Margin
EPS
How 603538.SS compares to sector?